"The fit for 2018 goal entails a huge sense of collaboration in order to come up with the best possible structure for us in the country…
In Conversation
"Our effective brand-building initiatives have been one of the main underpinnings of our success in terms of growth."
"Indonesia continues to be one of the key markets of GE Healthcare globally and the biggest one in the ASEAN region."
"The universal healthcare system (JKN) has been as efficient partner as we could have hoped for."
"We are committed to leveraging Novartis innovation and improving Indonesian patients’ lives."
"We have to give better options to patients to have more affordable and quality medicines through creating domestic manufacturing capabilities in the country and offer differentiated…
"We value the alternative medication market at close to USD 1.5 billion, adding USD 700 million for the supplement industry to the 800 million of the…
"Even though Sanofi is positioned as the top pharmaceutical MNC in the country, Indonesia is one of the most challenging markets in the SEA region where…
"In my opinion, JKN will certainly drive the growth of the national healthcare sector and life sciences industry in the future."
"Our overall healthcare strategy is to develop an integral solution that enables a treatment continuum between patients and doctors"
"Indonesia is still building its capabilities and, as the country is already a PIC/S’ member, there are very high standards in the industry."
"In my opinion, investing in educating stakeholders may not reap short term benefits but it will pay back on a long-term based on a loyal as…
